Skip to content

Form 4 filed by Venrock Healthcare Capital Partners III, L.P.

Venrock Healthcare Capital Partners III, L.P. filed this Form 4 on Lycia Therapeutics, Inc. with 5 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-30 23:25:13 UTC.

Accession
0001231919-26-001519
Filed
2026-10-30
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: Lycia Therapeutics, Inc. (CIK 1806540)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-28P bought+10,570$25.236,835,803I By Funds
Common Stock 2026-10-28P bought+4,430$25.976,840,233I By Funds
Common Stock 2026-10-29P bought+1,000$26.336,841,233I By Funds
Common Stock 2026-10-30P bought+8,804$26.276,850,037I By Funds
Common Stock 2026-10-30P bought+200$26.866,850,237I By Funds